Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation
- 1 June 2020
- journal article
- research article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 104 (5-6), 425-430
- https://doi.org/10.1159/000507351
Abstract
Purpose:The aim of this study was to investigate the influence of androgen deprivation therapy (ADT) on the progression of non-alcoholic fatty liver disease (NAFLD) in patients with prostate cancer (PCa) by evaluation of hepatic steatosis on computed tomography (CT).Methods:The study included 77 PCa patients who underwent abdominal CT at baseline and after 6 months of ADT. The degree of hepatic steatosis was evaluated according to the attenuation value for liver parenchyma (CTLP), the attenuation ratio for liver and spleen (LSratio), and the difference in attenuation between LS (LSdif). The associations between these 3 indices and various metabolic syndrome-related factors were analyzed.Results:The number of NAFLD patients increased from 9 (11.6%) at baseline to 16 (20.7%) after ADT. The CTLP, LSratio, and LSdif values were significantly lower after ADT than before (p< 0.05). There were significant correlations between the percent change in CTLP and the percent change in HbA(1c), between the percent change in LSratio and the percent change in abdominal circumference, and between the percent change in LSdif and the percent change in BMI.Conclusions:Six months of ADT was associated with significant progression of NAFLD in PCa patients. This progression was strongly correlated with changes in HbA(1c), abdominal circumference, and BMI.Keywords
This publication has 17 references indexed in Scilit:
- LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancerWorld Journal of Urology, 2016
- Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancerProstate Cancer and Prostatic Diseases, 2015
- NAFLD: A multisystem diseaseJournal of Hepatology, 2015
- Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer PatientsUrologia Internationalis, 2012
- A low level of serum total testosterone is independently associated with nonalcoholic fatty liver diseaseBMC Gastroenterology, 2012
- Activation of PKR/eIF2α signaling cascade is associated with dihydrotestosterone‐induced cell cycle arrest and apoptosis in human liver cellsJournal of Cellular Biochemistry, 2012
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortJournal of Hepatology, 2011
- Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved1H MR SpectroscopyRadiology, 2010
- Insulin Sensitivity during Combined Androgen Blockade for Prostate CancerJournal of Clinical Endocrinology & Metabolism, 2006
- Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemiaClinical Science, 2003